96 related articles for article (PubMed ID: 6600215)
1. Characterization of interleukin 2-dependent cytotoxic T-cell clones: specificity, cell surface phenotype, and susceptibility to blocking by Lyt antisera.
Palladino MA; Obata Y; Stockert E; Oettgen HF
Cancer Res; 1983 Feb; 43(2):572-6. PubMed ID: 6600215
[TBL] [Abstract][Full Text] [Related]
2. Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.
Kuribayashi K; Keyaki A; Sakaguchi S; Masuda T
Immunology; 1985 Sep; 56(1):127-40. PubMed ID: 3876271
[TBL] [Abstract][Full Text] [Related]
3. Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2.
Nakayama E; Uenaka A; Stockert E; Obata Y
Cancer Res; 1984 Nov; 44(11):5138-44. PubMed ID: 6091870
[TBL] [Abstract][Full Text] [Related]
4. Mouse alloantibodies capable of blocking cytotoxic T cell function. II. Further study on the relationship between the blocking antibodies and the products of the Lyt-2 locus.
Shinohara N; Hämmerling U; Sachs DH
Eur J Immunol; 1980 Aug; 10(8):589-94. PubMed ID: 6967414
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte lines reactive against murine plasmacytoma antigens: dissociation of cytotoxicity and Lyt-2 expression.
Giorgi JV; Zawadzki JA; Warner NL
Eur J Immunol; 1982 Oct; 12(10):831-7. PubMed ID: 6184236
[TBL] [Abstract][Full Text] [Related]
6. Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.
Keyaki A; Kuribayashi K; Sakaguchi S; Masuda T; Yamashita J; Handa H; Nakayama E
Immunology; 1985 Sep; 56(1):141-51. PubMed ID: 3876272
[TBL] [Abstract][Full Text] [Related]
7. Proliferative response of cloned CTL line 10B-5 upon stimulation with soluble clonotypic monoclonal antibody and its blocking by anti-Lyt-2 antibody.
Udono H; Kuribayashi K; Fujita T; Mieno M; Shiku H; Nakayama E
Immunobiology; 1989 Feb; 178(4-5):390-400. PubMed ID: 2785484
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
Waterfield JD; Nixon DF; Mair MG
Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
[TBL] [Abstract][Full Text] [Related]
9. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.
Giorgi JV; Warner NL
J Immunol; 1981 Jan; 126(1):322-30. PubMed ID: 6161166
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
[TBL] [Abstract][Full Text] [Related]
11. Characterization of interleukin 2 (IL-2)-dependent cytotoxic T-cell clones. V. Transfer of resistance to allografts and tumor grafts requires exogenous IL-2.
Palladino MA; Welte K; Carroll AM; Oettgen HF
Cell Immunol; 1984 Jul; 86(2):299-307. PubMed ID: 6610478
[TBL] [Abstract][Full Text] [Related]
12. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
13. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
Suzuki R; Handa K; Itoh K; Kumagai K
J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
[TBL] [Abstract][Full Text] [Related]
14. Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity.
Nakayama E; Shiku H; Takahashi T; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3486-90. PubMed ID: 91166
[TBL] [Abstract][Full Text] [Related]
15. Cytolytic activity of murine CD4+ T cell clones correlates with IFN-gamma production in mouse strains having a BALB/c background.
McKisic MD; Lancki DW; Fitch FW
J Immunol; 1993 May; 150(9):3793-805. PubMed ID: 8097225
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
17. Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency.
Katzav S; Segal S; Feldman M
J Natl Cancer Inst; 1985 Aug; 75(2):307-18. PubMed ID: 3894752
[TBL] [Abstract][Full Text] [Related]
18. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
[TBL] [Abstract][Full Text] [Related]
19. Mouse alloantibodies capable of blocking cytotoxic T cell function. III. Studies of the mechanism of blocking of CML by anti-Lyt-2 antibodies.
Shinohara N; Taniguchi M; Kojima M
J Immunol; 1981 Oct; 127(4):1575-8. PubMed ID: 6974198
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1.
Hogarth PM; Potter TA; Cornell FN; McLachlan R; McKenzie IF
J Immunol; 1980 Oct; 125(4):1618-24. PubMed ID: 6997382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
